Qingdao Haier Biomedical Co.,Ltd

SHSE:688139 Stock Report

Market Cap: CN¥11.8b

Qingdao Haier BiomedicalLtd Future Growth

Future criteria checks 5/6

Qingdao Haier BiomedicalLtd is forecast to grow earnings and revenue by 24.9% and 21.3% per annum respectively. EPS is expected to grow by 24.6% per annum. Return on equity is forecast to be 12.7% in 3 years.

Key information

24.9%

Earnings growth rate

24.6%

EPS growth rate

Medical Equipment earnings growth24.1%
Revenue growth rate21.3%
Future return on equity12.7%
Analyst coverage

Low

Last updated26 Apr 2024

Recent future growth updates

Recent updates

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Apr 26
Further Upside For Qingdao Haier Biomedical Co.,Ltd (SHSE:688139) Shares Could Introduce Price Risks After 33% Bounce

Earnings and Revenue Growth Forecasts

SHSE:688139 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20264,067793N/A8803
12/31/20253,704759N/A7074
12/31/20242,797521N/A6633
3/31/20242,28140633220N/A
12/31/20232,28140672249N/A
9/30/20232,615497385606N/A
6/30/20232,867579294562N/A
3/31/20232,987625358641N/A
12/31/20222,864601338632N/A
9/30/20222,68160882342N/A
6/30/20222,466573315559N/A
3/31/20222,276539334565N/A
12/31/20212,126845387592N/A
9/30/20211,941807556730N/A
6/30/20211,735799566681N/A
3/31/20211,549732708777N/A
12/31/20201,402381608697N/A
9/30/20201,266321427522N/A
6/30/20201,166254277409N/A
3/31/20201,078223116278N/A
12/31/20191,013182112280N/A
9/30/201995217327207N/A
12/31/201884211480149N/A
12/31/201762160N/A148N/A
12/31/2016482123N/A221N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 688139's forecast earnings growth (24.9% per year) is above the savings rate (2.9%).

Earnings vs Market: 688139's earnings (24.9% per year) are forecast to grow faster than the CN market (24.1% per year).

High Growth Earnings: 688139's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 688139's revenue (21.3% per year) is forecast to grow faster than the CN market (14.7% per year).

High Growth Revenue: 688139's revenue (21.3% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 688139's Return on Equity is forecast to be low in 3 years time (12.7%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy PolicyLogos provided by Clearbit
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.